Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1984 Sep;200(3):311–320. doi: 10.1097/00000658-198409000-00008

Inadequate interleukin 2 production. A fundamental immunological deficiency in patients with major burns.

J J Wood, M L Rodrick, J B O'Mahony, S B Palder, I Saporoschetz, P D'Eon, J A Mannick
PMCID: PMC1250477  PMID: 6331804

Abstract

We studied the production of the two major mediators of cellular immune responses, Interleukin 1 (IL-1) and Interleukin 2 (IL-2), by the peripheral blood mononuclear cells of 23 burn patients (16 men, seven women, mean age 48.9 years) compared with 23 matched controls (16 men, seven women, mean age 46.7 years). Serial measurements were made of IL-1 production by adherent mononuclear cells after stimulation with lipopolysaccharide and of IL-2 production by lymphocytes after stimulation with phytohemagglutinin (PHA). Eighty determinations of IL-2 production by lymphocytes from 12 patients with greater than 30% body surface area burn revealed a mean IL-2 production of 0.71 u as compared with a mean of 1.23 u for patients with less than 30% burns (p = 0.04). Patients with greater than 30% body surface area burns had significantly reduced IL-2 production (p less than or equal to 0.05) until 60 days after injury, whereas those with smaller burns had reduced IL-2 production only at 20-29 and 30-39 days postburn. Nine burn patients with systemic sepsis showed significantly lower IL-2 production (p = 0.03) at 10-29 days postburn than nonseptic patients, and significantly less IL-2 production during septic episodes. Eight patients with greater than 50% suppression of lymphocyte response to PHA produced less IL-2 (0.4 u) than patients with less than 50% suppression, (1.07 u, p = 0.004). IL-1 production was significantly elevated as compared with controls (4.45 u vs. 3.6 u, p = 0.05) early after injury, but was subsequently within the normal range regardless of burn size. The percentage of circulating helper T-lymphocytes, the principal source of IL-2, was also reduced, although this did not always correlate with IL-2 production, which remained depressed after recovery of the helper T-cell population. These results indicate that failure to produce IL-2, a powerful mediator of cellular immune responses, is an important mechanism underlying the defective cell mediated immunity seen in burn patients.

Full text

PDF
311

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander J. W., Moncrief J. A. Alterations of the immune response following severe thermal injury. Arch Surg. 1966 Jul;93(1):75–83. doi: 10.1001/archsurg.1966.01330010077011. [DOI] [PubMed] [Google Scholar]
  2. Baker C. C., Miller C. L., Trunkey D. D., Lim R. C., Jr Identity of mononuclear cells which compromise the resistance of trauma patients. J Surg Res. 1979 May;26(5):478–487. doi: 10.1016/0022-4804(79)90037-4. [DOI] [PubMed] [Google Scholar]
  3. Baker C. C., Miller C. L., Trunkey D. D. Predicting fatal sepsis in burn patients. J Trauma. 1979 Sep;19(9):641–648. doi: 10.1097/00005373-197909000-00001. [DOI] [PubMed] [Google Scholar]
  4. Baker C. C., Oppenheimer L., Stephens B., Lewis F. R., Trunkey D. D. Epidemiology of trauma deaths. Am J Surg. 1980 Jul;140(1):144–150. doi: 10.1016/0002-9610(80)90431-6. [DOI] [PubMed] [Google Scholar]
  5. Cantrell D. A., Smith K. A. Transient expression of interleukin 2 receptors. Consequences for T cell growth. J Exp Med. 1983 Dec 1;158(6):1895–1911. doi: 10.1084/jem.158.6.1895. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Casson P., Solowey A. C., Converse J. M., Rapaport F. T. Delayed hypersensitivity status of burned patients. Surg Forum. 1966;17:268–270. [PubMed] [Google Scholar]
  7. Chouaib S., Chatenoud L., Klatzmann D., Fradelizi D. The mechanisms of inhibition of human IL 2 production. II. PGE2 induction of suppressor T lymphocytes. J Immunol. 1984 Apr;132(4):1851–1857. [PubMed] [Google Scholar]
  8. Chouaib S., Fradelizi D. The mechanism of inhibition of human IL 2 production. J Immunol. 1982 Dec;129(6):2463–2468. [PubMed] [Google Scholar]
  9. Constantian M. B., Menzoian J. O., Nimberg R. B., Schmid K., Mannick J. A. Association of a circulating immunosuppressive polypeptide with operative and accidental trauma. Ann Surg. 1977 Jan;185(1):73–79. doi: 10.1097/00000658-197701000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Farrar W. L., Johnson H. M., Farrar J. J. Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2. J Immunol. 1981 Mar;126(3):1120–1125. [PubMed] [Google Scholar]
  11. Fishbein E., Alcocer-Varela J., Alarcón-Segovia D. Cellular bases of the production of and response to interleukin-2 in man: role of autologous rosette-forming T-cell subsets defined with monoclonal antibodies. Immunology. 1983 Oct;50(2):223–227. [PMC free article] [PubMed] [Google Scholar]
  12. Gery I., Gershon R. K., Waksman B. H. Potentiation of the T-lymphocyte response to mitogens. I. The responding cell. J Exp Med. 1972 Jul 1;136(1):128–142. doi: 10.1084/jem.136.1.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gery I., Waksman B. H. Potentiation of the T-lymphocyte response to mitogens. II. The cellular source of potentiating mediator(s). J Exp Med. 1972 Jul 1;136(1):143–155. doi: 10.1084/jem.136.1.143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gillis S., Ferm M. M., Ou W., Smith K. A. T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol. 1978 Jun;120(6):2027–2032. [PubMed] [Google Scholar]
  15. Gillis S., Kozak R., Durante M., Weksler M. E. Immunological studies of aging. Decreased production of and response to T cell growth factor by lymphocytes from aged humans. J Clin Invest. 1981 Apr;67(4):937–942. doi: 10.1172/JCI110143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hansbrough J., Peterson V., Zapata-Sirvent R., Claman H. N. Postburn immunosuppression in an animal model. II. Restoration of cell-mediated immunity by immunomodulating drugs. Surgery. 1984 Mar;95(3):290–296. [PubMed] [Google Scholar]
  17. Hefeneider S. H., Conlon P. J., Henney C. S., Gillis S. In vivo interleukin 2 administration augments the generation of alloreactive cytolytic T lymphocytes and resident natural killer cells. J Immunol. 1983 Jan;130(1):222–227. [PubMed] [Google Scholar]
  18. McIrvine A. J., Wolfe J. H., Collins K., Mannick J. A. Fatal infection in mice after injection of immunosuppressive serum fractions from surgical patients. Br J Surg. 1983 Sep;70(9):558–561. doi: 10.1002/bjs.1800700917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Miller C. L., Baker C. C. Changes in lymphocyte activity after thermal injury. The role of suppressor cells. J Clin Invest. 1979 Feb;63(2):202–210. doi: 10.1172/JCI109290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Munster A. M. Post-traumatic immunosuppression is due to activation of suppressor T cells. Lancet. 1976 Jun 19;1(7973):1329–1330. doi: 10.1016/s0140-6736(76)92658-1. [DOI] [PubMed] [Google Scholar]
  21. Murphy P. A., Simon P. L., Willoughby W. F. Endogenous pyrogens made by rabbit peritoneal exudate cells are identical with lymphocyte-activating factors made by rabbit alveolar macrophages. J Immunol. 1980 May;124(5):2498–2501. [PubMed] [Google Scholar]
  22. Robb R. J. Human T-cell growth factor: purification biochemical characterization, and interaction with a cellular receptor. Immunobiology. 1982 Mar;161(1-2):21–50. doi: 10.1016/S0171-2985(82)80018-1. [DOI] [PubMed] [Google Scholar]
  23. Smith K. A., Lachman L. B., Oppenheim J. J., Favata M. F. The functional relationship of the interleukins. J Exp Med. 1980 Jun 1;151(6):1551–1556. doi: 10.1084/jem.151.6.1551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Solbach W., Barth S., Röllinghoff M., Wagner H. Interactions of human T cell subsets during the induction of cytotoxic T lymphocytes: the role of interleukins. Clin Exp Immunol. 1982 Jul;49(1):167–175. [PMC free article] [PubMed] [Google Scholar]
  25. Tsang K. Y., Fudenberg H. H., Galbraith G. M. In vitro augmentation of interleukin-2 production and lymphocytes with the TAC antigen marker in patients with AIDS. N Engl J Med. 1984 Apr 12;310(15):987–987. doi: 10.1056/NEJM198404123101513. [DOI] [PubMed] [Google Scholar]
  26. Wang B. S., Heacock E. H., Wu A. V., Mannick J. A. Generation of suppressor cells in mice after surgical trauma. J Clin Invest. 1980 Aug;66(2):200–209. doi: 10.1172/JCI109845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Wolfe J. H., Saporoschetz I., Young A. E., O'Connor N. E., Mannick J. A. Suppressive serum, suppressor lymphocytes, and death from burns. Ann Surg. 1981 Apr;193(4):513–520. [PMC free article] [PubMed] [Google Scholar]
  28. Wolfe J. H., Wu A. V., O'Connor N. E., Saporoschetz I., Mannick J. A. Anergy, immunosuppressive serum, and impaired lymphocyte blastogenesis in burn patients. Arch Surg. 1982 Oct;117(10):1266–1271. doi: 10.1001/archsurg.1982.01380340002002. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES